Related references
Note: Only part of the references are listed.Evolution of the DAN gene family in vertebrates
Juan C. Opazo et al.
DEVELOPMENTAL BIOLOGY (2022)
Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes
Tsuyoshi Isojima et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Notum Deletion From Late-Stage Skeletal Cells Increases Cortical Bone Formation and Potentiates Skeletal Effects of Sclerostin Inhibition
Roy B. Choi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Improving Bone Health by Optimizing the Anabolic Action of Wnt Inhibitor Multitargeting
Roy B. Choi et al.
JBMR PLUS (2021)
Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST
Gregory R. Gipson et al.
BIOCHEMICAL JOURNAL (2020)
Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism
Kyung Shin Kang et al.
BONE (2019)
Sostdcl: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells
Z. Faraahi et al.
BONE (2019)
Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1
J. Kim et al.
JOURNAL OF DENTAL RESEARCH (2019)
Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
Whitney A. Bullock et al.
ISCIENCE (2019)
Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition
Phillip C. Witcher et al.
JCI INSIGHT (2018)
Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells
Nicole M. Collette et al.
BONE (2016)
Cortical-Bone Fragility - Insights from sFRP4 Deficiency in Pyle's Disease
Pelin O. Simsek Kiper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Monica Florio et al.
NATURE COMMUNICATIONS (2016)
Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development
Yumiko Togo et al.
PLOS ONE (2016)
US population aging and demand for inpatient services
Daniel J. Pallin et al.
JOURNAL OF HOSPITAL MEDICINE (2014)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Inhibition of WISE Preserves Renal Allograft Function
Xueming Qian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Maarten van Dinther et al.
PLOS ONE (2013)
Conditionals by inversion provide a universal method for the generation of conditional alleles
Aris N. Economides et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk
Hou-Feng Zheng et al.
PLOS GENETICS (2012)
Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men
Jin-Wei He et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning
Youngwook Ahn et al.
DEVELOPMENT (2010)
Genetic evidence that SOST inhibits WNT signaling in the limb
Nicole M. Collette et al.
DEVELOPMENTAL BIOLOGY (2010)
Inhibition of Sclerostin by Monoclonal Antibody Increases Bone Formation, Bone Mass, and Bone Strength in Aged Male Rats
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome
Mari Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Lrp4 Modulates Extracellular Integration of Cell Signaling Pathways in Development
Atsushi Ohazama et al.
PLOS ONE (2008)
Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation
Christina N. Bennett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity
Debra L. Ellies et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury
M Yanagita et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of mammalian tooth cusp patterning by ectodin
Y Kassai et al.
SCIENCE (2005)
USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney
M Yanagita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity
N Kusu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
